Back to mobile site

BTIG Reiterates Buy Rating on Abbott Labs (ABT)

August 22, 2024 5:40 AM EDT Send to a Friend
BTIG analyst Marie Thibault reiterated a Buy rating and $135.00 price target on Abbott Labs (NYSE: ABT).The analyst comments "During ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login